1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow AG regimen: new trials by email Literature Review of AG regimen trials Research Report on AG regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer Nab paclitaxel plus gemcitabine, mFOLFIRINOX - Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma | Phase 3 | Unknown | Fudan University | 300 | 2021-09-01 | 2022-01-28 |
| Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer AG regimen, mFolfirinox - Pancreatic Adenocarcinoma Resectable, Neoadjuvant Chemotherapy | Phase 3 | Completed | Second Affiliated Hospital, Zhejiang University, School of Medicine | 324 | 2018-10-20 | 2025-05-13 |
Fudan University (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1)
China (2)
Tingbo Liang, MD PhD (1) · Xian-Jun Yu, MD, PhD (1)